Krystexxa is a prescription medicine used to treat the symptoms of Gout. Krystexxa may be used alone or with other medications.
Krystexxa belongs to a class of drugs called Enzymes, Oncology; Rheumatologics, Other.
The recommended dose and regimen of KRYSTEXXA for adult patients is 8 mg (uricase protein) given as an intravenous infusion every two weeks.
Intravenous
Minutes
2
Weeks
The serious side effects can include:
There are several programs patients can sign up for that will assist in treatment costs:
To learn more about this treatment, browse the resources below.
Contact us to chat with one of our helpful scheduling specialists!